Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Randall Graham

Neurological Surgery Dallas, TX Medical Doctor

NPI 1174834295 CMS profile 53089

1411 N Beckley Ave, Pavilion III Suite 152, Dallas, TX 75203

Open in the dashboard

General payments

$138,216

345 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Randall Graham of Dallas, TX is reported in the CMS Open Payments database as having received $138,216 across 345 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $40,248 54
2024 General $31,367 74
2023 General $26,129 48
2022 General $9,367 24
2021 General $13,034 29
2020 General $8,338 21
2019 General $9,732 95

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Randall Graham
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Randall Graham were reported at $40,248. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Randall Graham Neurological Surgery median Middle half National median
2019 $9,732 $582 $138–$3,006 $163
2020 $8,338 $294 $76–$2,174 $114
2021 $13,034 $387 $105–$2,432 $132
2022 $9,367 $542 $139–$2,989 $149
2023 $26,129 $534 $145–$2,697 $160
2024 $31,367 $574 $155–$3,046 $164
2025 $40,248 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. NuVasive, Inc. $62,429 167 payments
  2. Medtronic, Inc. $39,910 74 payments
  3. Globus Medical, Inc. $31,416 55 payments
  4. Seaspine Orthopedics Corporation $1,839 10 payments
  5. 4WEB, Inc. $1,070 2 payments
  6. Spineart USA Inc $347 1 payment
  7. MML US, Inc. $193 1 payment
  8. Medtronic USA, Inc. $171 7 payments
  9. Spinal Elements, Inc. $136 1 payment
  10. DePuy Synthes Sales Inc. $112 3 payments
  11. Other $591 24 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $102,300 38 payments
  2. Travel and Lodging $26,711 129 payments
  3. Food and Beverage $9,182 177 payments
  4. Entertainment $23 1 payment
Products named General payments · program years 2019–2025
  1. XLIF Spine/Spine Surgery $48,558 87 payments
  2. XLIF Spine/Spine Surgery $13,997 41 payments
  3. CATALYFT PL EXPANDABLE INTERBODY SYSTEM $8,608 9 payments
  4. ExcelsiusGPS Robotic Navigation System $7,736 8 payments
  5. TLIF $3,549 6 payments
  6. ALIF $3,030 8 payments
  7. Pulse Spine/Spine Surgery $2,299 27 payments
  8. UNID_PASS $1,501 16 payments
  9. Pulse Spine/Spine Surgery $1,351 6 payments
  10. Mariner $1,306 5 payments
  11. Other $12,498 199 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

83

Median for Neurosurgery: 83

Drug cost

$1,045

Median for Neurosurgery: $872

Branded share of claims

83.1%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 69 $911
Methocarbamol Generic 14 $133

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 46 billing codes

Paid by Medicare

$129,941

Medicare's payments for the services billed

Medicare patients

146

Average age 74

Services billed

412

83 women, 63 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 40%
Diabetes 39%
Chronic kidney disease 34%
Depression 29%
Heart failure 27%
Osteoporosis 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

345 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record